Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH- releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 285-290

  Ghigo, E ^b   Gianotti, L ^b   Arvat, E ^b   Ramunni, J ^b   Valetto, M R ^b   Broglio, F ^b   Rolla, M ^b   Cavagnini, F ^b   Muller E E ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GHRH 29; GLUCOSE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HEXARELIN; INSULIN; SOMATOMEDIN; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FLUSHING; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE SENSITIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INJECTION PAIN; INSULIN BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; NEGATIVE FEEDBACK; NORMAL HUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; FEMALE; GROWTH HORMONE-RELEASING HORMONE; GROWTH SUBSTANCES; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OLIGOPEPTIDES; RECOMBINANT PROTEINS;

EID: 0032905676     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.285     Document Type: Article

References (46)

1. 1. Berelowitz M, Szabo M, Frohman LA, Firestone S, Hintz RL. 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science. 212:1279-1281.
2. 2. Abe H, Molitch ME, Van Wyk JJ, Underwood LE. 1983 Human growth hormone and somatomedin C suppress the spontaneous release of growth hormone in unanesthetized rats. Endocrinology. 113:1319-1324.
3. 3. Tannembaum GS, Guyda HJ, Posner BI. 1983 Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science. 220:77-79.
4. 4. Ceda GP, Davis RG, Rosenfeld RG, Hoffman AR. 1987 The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II. Endocrinology. 120:1658-1662.
5. 5. Guler HP, Zapf J, Froesch ER. 1987 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med. 317:137-140.
6. 6. Guler HP, Schmid C, Zapf J, Froesch ER. 1989 Effect of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA. 86:2868-2872.
7. 7. Laron Z, Klinger B, Jensen LT, Erster B. 1991 Biochemical and hormonal changes induced by one week of administration of rhIGF-I to patients with Laron type dwarfism. Clin Endocrinol (Oxf). 35;145-150.
8. 8. Spencer GSG, Macdonald AA, Buttle HL, Moore LG, Carlyle SS. 1991 Intracerebral administration of insulin-like growth factor I decreases circulating growth hormone levels in the fetal pig. Acta Endocrinol (Copenh). 124:563-568.
9. 9. Hartman ML, Clayton PE, Johnson ML, et al. 1993 A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans. J Clin Invest. 91:2453-2462.
10. 10. Fletcher TP, Thomas GB, Dunshea FR, Moore LG, Clarke IJ. 1995 IGF feedback effects on growth hormone secretion in ewes: evidence for action at the pituitary but not the hypothalamic level. J Endocrinol. 144:323-331.
11. 11. Chapman IM, Hartman ML, Pezzoli SS, et al. 1997 Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback. J Clin Endocrinol Metab. 82:2996-3004.
12. 12. Bohannon NJ, Figlewicz DP, Corp ES, Wilcox J, Porte D, Baskin DG. 1986 Identification of binding sites for an insulin-like growth factor (IGF-I) in the median eminence of the rat brain by quantitative autoradiography. Endocrinology. 119:943-945.
13. 13. Yamashita S, Melmed S. 1986 Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
14. 14. Shimon I, Yan X, Melmed S. 1998 Human fetal pituitary expresses functional growth hormone-releasing peptide receptors. J Clin Endocrinol Metab. 83:1744-1748.
15. 15. Sato M, Frohman LA. 1993 Differential effects of central and peripheral administration of GH and insulin-like growth factor on hypothalamic GH-releasing hormone and somatostatin gene expression in GH-deficient dwarf rats. Endocrinology. 133:793-799.
16. 16. Shibasaki T, Yamauchi N, Hotta M, et al. 1986 In vitro release of growth hormone-releasing factor from rat hypothalamus: effect of insulin-like growth factor-I. Regul Pept. 15:47-51.
17. 17. Harel Z, Tannembaum GS. 1992 Synergistic interaction between insulin-like growth factors I and II in central regulation of pulsatile growth hormone secretion. Endocrinology. 131:758-764.
18. 18. Jenkins RC, Ross RJM. 1996 Acquired growth hormone resistance in catabolic states. Baillieres Clin Endocrinol Metab. 10;3:411-419.
19. 19. Thissen J, Ketelslegers JM, Underwood LE. 1994 Nutritional regulation of the insulin-like growth factors. Endocr Rev. 15:80-101.
20. 20. Vaccarello MA, Diamond FB, Guevara-Aguirre J, et al. 1993 Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 77:273-280.
21. 21. Cheetham TD, Clayton K, Taylor AM, Holly J, Matthews DR, Dunger DB. 1994 The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin-dependent diabetes mellitus. Clin Endocrinol (Oxf). 40:515-522.
22. 22. Trainer PJ, Holly J, Medbak S, Rees LH, Besser GM. 1994 The effect of recombinant IGF-I on anterior pituitary function in healthy volunteers. Clin Endocrinol (Oxf). 41:801-807.
23. 23. Laron Z, Klinger B, Silbergeld A, Lewin R, Erster B, Gil-Ad I. 1990 Intravenous administration of recombinant IGF-I lowers serum GHRH and TSH. Acta Endocrinol (Copenh). 123:378-382.
24. 24. Laron Z, Erster B, Klinger B, Anin S. 1988 Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism. Lancet 11:1171-1172.
25. 25. Bowers CY, Veeraragavan K, Sethumadhavan K. 1993 Atypical growth hormone-releasing peptides. In: Bercu BB, Walker RF, eds. Growth hormone II. Basic and clinical aspects. New York: Springer-Verlag; 205-222.
26. 26. Ghigo E, Arvat E, Muccioli G, Camanni F. 1997 Growth hormone-releasing peptides. Eur J Endocrinol. 136:445-460.
27. 27. Smith R, Van der Ploeg L, Howard A, et al. 1997 Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 18:621-645.
28. 28. Popovic V, Damjanovic S, Micic D, Djurovic M, Dieguez C, Casanueva FF. 1995 Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamo-pituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab. 80:942-947.
29. 29. Muccioli G, Ghè C, Ghigo MC, et al. 1998 Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland. J Endocrinol. 157:99-106.
30. 30. Ong H, McNicoll N, Escher F, et al. 1998 Identification of a pituitary GHRP receptor subtype by the fotoaffinity labeling approach using I125 p-benzoyl-phenylalanine hexarelin derivative. Endocrinology. 139:432-435.
31. 31 Thoren MC, Wivall-Helleryd IL, Blum WF, Hall KE. 1994 Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol. 131:33-40.
32. 32. Baumann G. 1994 Growth hormone binding protein and growth hormone sensitivity. Endocrinol Metab Clin North Am. [Suppl A] 1:21-25.
33. 33. Wehrenberg WB, Giustina A. 1992 Mechanisms and pathways of gonadal steroid modulation of growth hormone secretion. Endocr Rev. 13:281-298.
34. 34. Dieguez C, Page MD, Scanlon MF. 1988 Growth regulation and its alteration in disease states. Clin Endocrinol (Oxf). 28:109-143.
35. 35. Veldhuis JD. 1996 New modalities for understanding dynamic regulation of the somatotropic (GH) axis: explication of gender differences in GH neuroregulation in the human. J Pediatr Endocrinol Metab. 9:237-253.
36. 36. Barinaga M, Bilezikjian LM, Vale WW, Rosenfeld MG, Evans RM. 1985 Independent effects of growth hormone-releasing factor on growth hormone release and gene transcription. Nature. 314:279-281.
37. 37. Ghigo MC, Torsello A, Grilli R, et al. 1997 Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: a study on ad libitum fed and starved adult male rats. J Endocrinol Invest. 20:144-150.
38. 38. Ghigo E, Arvat E, Bellone J, Ramunni J, Camanni F. 1993 Neurotransmitter control of growth hormone secretion in humans. J Pediatr Endocrinol Metab. 6:263-266.
39. 39. Goth MI, Lyons CE, Canny BY, Thorner MO. 1992 Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology. 130:939-944.
40. 40. Arvat E, Gianotti L, Grottoli S, et al. 1995 Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology. 61:51-56.
41. 41. Massoud AF, Hindmarsh PC, Brook CGD. 1995 Hexarelin induced growth hormone release is influenced by exogenous growth hormone. Clin Endocrinol (Oxf). 43:617-621.
42. 42. Guillame V, Magnan E, Cataldi M, et al. 1994 Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology. 135:1073-1076.
43. 43. Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. 1998 Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab. 83:1186-1189.
44. 44. Tannembaum GS. 1980 Evidence for autoregulation of growth hormone secretion via the central nervous system. Endocrinology. 107:2117-2120.
45. 45. Jacks T, Hickey G, Judith F, et al. 1994 Effects of acute and repeated intravenous administration of L-692,585, a novel nonpeptidyl growth hormone secretagogue, on plasma growth hormone, IGF-I, ACTH, cortisol, prolactin, insulin and thyroxine levels in beagles. J Endocrinol. 143:399-406.
46. 46. Bennet PA, Thomas GB, Howard AD, et al. 1997 Hypothalamic growth hormone secretagogue-receptor (GHS-R) expression is regulated by growth hormone in the rat. Endocrinology. 138:4552-4557.